Diversey 11x12in Oxivir Tb Disinfectant Wipes 4x 160 Count Refill Packs SKU#Diversey-100823906

Manufacturer:	Diversey
Part No:	100823906
SKU:	Diversey-100823906

Product Description:

Consult The US EPA N-List For Virucides Approved For Use Against The COVID-19 Coronavirus

Diversey 11x12in Oxivir Tb Disinfectant Wipes 4x 160 Count Refill Packs SKU#Diversey-100823906 - 11x12in Wipes. Oxivir Tb disinfectant wipes are made with Hydrogen Peroxide (AHP) technology to maintain a sanitary environment. 60 second kill time, effective against key pathogens - Tb, MRSA, Norovirus, VRE. Kills HBV, HCV and HIV in 1 minute. Tuberculocidal in 5 minutes and Fungicidal in 10 minutes. Non-allergenic wipes have no added fragrances or volatile organic compounds and are non-irritating to eyes and skin. EPA and FDA Certifications. Meets bloodborne pathogen standards for decontaminating blood and body fluids. Colorless with a characteristic scent. Ideal for use around patients, by visitors, and on common area surfaces. Each Oxivir Tb Refill Pack contains 160 Wipes, 4 Refill Packs (640 Wipes) per Case.

Oxivir Tb Efficacy Against The SARS-CoV-2 Coronavirus

Oxivir Tb (EPA Registration 70627-56) appears on US EPA's List N for Use Against SARS-CoV-2. The EPA has stated the following:
"EPA expects the products on List N to kill SARS-CoV-2, the coronavirus that causes COVID-19, because they:

• Demonstrate efficacy against the coronavirus SARS-CoV-2 (COVID-19);
• Demonstrate efficacy against a pathogen that is harder to kill than SARS-CoV-2 (COVID-19); or
• Demonstrate efficacy against a different human coronavirus similar to SARS-CoV-2 (COVID-19).

EPA expects all products on List N to be effective against SARS-CoV-2 (COVID-19) when used according to label directions."

Below is the screenshot showing Oxivir Tb on EPA's List N

How it is listed shows that The EPA expects Oxivir Tb to be effective against SARS-CoV-2 because it has demonstrated efficacy against a pathogen that is harder to kill than SARS-CoV-2.For disinfectants registered with The EPA, companies are not allowed to label against a specific virus or bacteria until the efficacy data has been reviewed and approved by The EPA. Once the efficacy data has been developed, this approval process takes about 3 months for The EPA to approve a product. Diversey is currently in the process of submitting the data for Oxivir Tb to The EPA.

Diversey Coronavirus Webinar Video

DOBMEIER IS YOUR PREMIER DIVERSEY DISTRIBUTOR IN NEW YORK STATE. WE OFFER BEST AVAILABLE DISCOUNT ON ALL VIRUCIDAL DISINFECTION SUPPLIES & SHIP ANYWHERE IN NORTH AMERICA. FOR BEST AVAILABLE DISCOUNT ON YOUR ORDER CALL 1.800.870.2006

Downloadable Diversey COVID-19 Information Documents

Diversey Coronavirus Webinar Slides
Diversey COVID-19 Brochure
Diversey COVID-19 Outbreak Fact Sheet

Product image may vary from product if manufacturer changes specifications.

Product Specifications:
COVID-19